Urinary P75: a promising biomarker for amyotrophic lateral sclerosis
Background Amyotrophic lateral sclerosis (ALS) is a progressive and fatal disease. The urinary neurotrophin receptor p75 extracellular domain (p75ECD) has previously been reported as a potential disease biomarker for diagnosis, severity assessment and monitoring therapeutic response.Methods This stu...
Saved in:
| Main Authors: | Martin R Turner, Andrea Malaspina, Pamela J Shaw, Stephanie Shepheard, Nick Verber, Mary-Louise Rogers, Laura R Chapman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Neurology Open |
| Online Access: | https://neurologyopen.bmj.com/content/7/2/e001088.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glutathione oxidation in cerebrospinal fluid as a biomarker of oxidative stress in amyotrophic lateral sclerosis
by: Trong Khoa Pham, et al.
Published: (2025-07-01) -
Management of Dysarthria in Amyotrophic Lateral Sclerosis
by: Elena Pasqualucci, et al.
Published: (2025-07-01) -
The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis
by: Alexander Bampton, et al.
Published: (2024-11-01) -
Genetics of familial amyotrophic lateral sclerosis
by: A. V. Savinova, et al.
Published: (2021-10-01) -
Characterization of lower urinary tract dysfunction in a mouse model of amyotrophic lateral sclerosis
by: Ching-Yi Lin, et al.
Published: (2025-08-01)